AroCell AB (publ)
SSE:AROC.ST
Overview | Financials
Company Name | AroCell AB (publ) |
Symbol | AROC.ST |
Currency | SEK |
Price | 0.405 |
Market Cap | 93,296,205 |
Dividend Yield | 0% |
52-week-range | 0.374 - 0.777 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Anders Hultman B.Sc., BSc |
Website | https://www.arocell.com |
An error occurred while fetching data.
About AroCell AB (publ)
AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD